- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4098EUR$4,500USD£3,524GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3187EUR$3,500USD£2,741GBP
- Report
- December 2021
Global
From €4417EUR$4,850USD£3,798GBP
- Report
- October 2024
Global
From €3187EUR$3,500USD£2,741GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2504EUR$2,750USD£2,154GBP
The Campylobacter Test market is a segment of the Infectious Disease Testing industry. It is used to detect the presence of Campylobacter bacteria, which can cause gastrointestinal illness. Tests are typically performed on stool samples, and can be used to diagnose an infection, monitor treatment, or detect the presence of the bacteria in food or water. Tests are available in both laboratory-based and point-of-care formats.
The Campylobacter Test market is highly competitive, with a range of companies offering products. These include bioMérieux, Becton Dickinson, Cepheid, DiaSorin, Hologic, Meridian Bioscience, Quidel, and Thermo Fisher Scientific. Show Less Read more